Predictors of Index Patient Acceptance of Expedited Partner Therapy for Chlamydia trachomatis Infection and Reasons for Refusal, Sexually Transmitted Disease Clinics, New York City, 2011 to 2012
- 1 November 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 41 (11) , 690-694
Abstract
Background Expedited partner therapy (EPT) for Chlamydia trachomatis (Ct) reduces repeat Ct infection and was legalized in New York State in 2009. It is a practice in which a Ct-infected index patient delivers medication or a prescription directly to sex partner(s), without those partners receiving medical evaluation. There have been few evaluations of EPT implementation assessing acceptance and uptake among index patients. We measured EPT acceptance among index patients, identified predictors of accepting EPT, and described reasons for declining EPT. Methods We conducted a retrospective analysis using electronic medical records from patients attending New York City Department of Health and Mental Hygiene STD clinics from July 2011 to October 2012. A multivariable model examined the associations between accepting EPT and patient and clinic-level characteristics. Results Overall, 54.8% (1076/1964) of index patients accepted EPT when offered (55.9% of males and 54.4% of females [P = 0.55]). Predictors of EPT acceptance included having a male provider offer EPT (adjusted odds ratio, 1.43; 95% confidence interval, 1.12–1.83). Index patients who had a partner present at the clinic during the treatment visit were less likely to accept EPT (adjusted odds ratio, 0.28; 95% confidence interval, 0.20–0.40). Among 888 patients who refused EPT, common reasons were as follows: “partner in clinic today for treatment” (26.3% [234/888]), “no longer with partner” (25.0% [222/888]), “partner already treated” (20.3% [180/888]), and “prefer medication be delivered by clinician” (19.6% [174/888]). Expedited partner therapy acceptance did not differ by patient age, sex, or race. Excluding persons whose partners were already treated and persons whose partners were in the clinic for treatment, EPT acceptance rates were 69.4%. Conclusions Expedited partner therapy acceptance rates were high among index patients whose partners were not otherwise treated.Keywords
This publication has 11 references indexed in Scilit:
- Use of expedited partner therapy among chlamydia cases diagnosed at an urban Indian health centre, ArizonaInternational Journal of STD & AIDS, 2013
- Implementation and Effectiveness of an Expedited Partner Therapy Program in an Urban ClinicSexually Transmitted Diseases, 2012
- Expedited Partner Therapy: A Robust InterventionSexually Transmitted Diseases, 2010
- Evaluation of a Population-Based Program of Expedited Partner Therapy for Gonorrhea and Chlamydial InfectionSexually Transmitted Diseases, 2007
- Patient-Delivered Partner Treatment for Male Urethritis: A Randomized, Controlled TrialClinical Infectious Diseases, 2005
- Not all patients want to participate in decision makingJournal of General Internal Medicine, 2005
- Effect of Expedited Treatment of Sex Partners on Recurrent or Persistent Gonorrhea or Chlamydial InfectionNew England Journal of Medicine, 2005
- Physician Gender Effects in Medical CommunicationJAMA, 2002
- Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory diseaseAmerican Journal of Obstetrics and Gynecology, 1997
- Tubal factor infertility: an association with prior chlamydial infection and asymptomatic salpingitisFertility and Sterility, 1988